1 2 3 4 5 6 7 8 9 10 11
далее Lancet 1997; 349: 462-466. 18. Gordon D. 0., John W. G. C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the speedwell study. Arterioscler., Thromb., Vase. Biol. 2001; 23: 603. 19. Buffon A., Liuzzo G., Biasucci L. М. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J. Am. Coll. Cardiol. 1999; 34: 1512-1520. 20. Liuzzo G., Biasucci L. М., Gallimore J. R. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N. Engi J. Med. 1994; 331: 417—424. 21. Toss Н., Lindahl В., Sicgbahn A. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation 1997; 96: 4204—4210. 22. Vainas Т., Lubbers T. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurismal tissue. Circulation 2003; 107: 1103. 23. van der Meer I. М., Moniek P. М. C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree. 2002. 24. Yudkin J. S., Stehouwer C. D., Emeis J. J. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vase. Biol. 1999; 19: 972-976. 25. Mendall М. A., Strachan D. P. C-reactive protein: relation to total mortality, cardiovascular risk factors for men. Eur. Heart J. 2001; 21: 2584-2590. 26. Miller A. P., Yiu-Fai Chen, Dongqi Xing; Wenguang Feng. Hormone replacement therapy and inflammation. Hypertension 2003; 42: 657. 27. Josi Manuel Fernandez-Real, Wifredo Ricart. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocrine Rev. 2003; 24 (З): 278-301. 28. Grundy S. М. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 2002; 105: 2696—2698. 29. Block G., Jensen Ch. et al. Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation. J. Am. Coll. Nutr. 2004; 23 (2): 141—147. 30. Festa A., D'Agostino R., Tracy R. P., Haflher S. М. Elevated levels of acute-phase proteins and plasminogen activator inhibitor- 1 predict the development of type 2 diabetes. The Insulin Resistance Atherosclerosis Study. Diabetes 2000; 51: 1131— 1137. 31. Imhof A., Woodward М. et al. Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow,Lille). Eur. Heart. J. 2004; 25: 2092-2100. 32. Zairis M. N., Ambrose J. A. C-reactive protein, moderate alcohol consumption, and long term prognosis after successful coronary stenting: four year results from the GENERATION study. Heart 2004; 90: 419-424. 33. Ridker P. M., Rifai N., Pfeffer M. A. Long-te'rm effects of pravastatin on plasma concentration of C-reactive protein. Circulation 1999; 100: 230-235. 34. McCullough P. A., McCarey далее ...